70518-1551 Ondansetron

Product NDC:

70518-1551

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 8.0

Unit: mg/1

Packages:

Code: 70518-1551-00

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (70518-1551-0)

Effective Date: Oct. 23, 2018

Discontinued:

Code: 70518-1551-01

Description: 3 BLISTER PACK in 1 CARTON (70518-1551-1) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Effective Date: May 1, 2019

Discontinued: Feb. 18, 2020

Code: 70518-1551-02

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (70518-1551-2)

Effective Date: Nov. 21, 2023

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox